RXO (NYSE:RXO) Price Target Raised to $20.00 at The Goldman Sachs Group

RXO (NYSE:RXO) had its price target increased by The Goldman Sachs Group from $18.00 to $20.00 in a report released on Thursday,Benzinga reports. They currently have a neutral rating on the stock.

Several other equities research analysts also recently issued reports on RXO. Wall Street Zen raised shares of RXO from a “sell” rating to a “hold” rating in a research note on Saturday, May 9th. Stifel Nicolaus upped their price objective on shares of RXO from $22.00 to $30.00 and gave the company a “buy” rating in a research report on Monday. Bank of America lowered their target price on RXO from $17.00 to $15.00 and set a “neutral” rating for the company in a research note on Wednesday, March 25th. Barclays lifted their target price on RXO from $20.00 to $28.00 and gave the stock an “overweight” rating in a research report on Thursday, June 25th. Finally, Truist Financial boosted their price target on RXO from $26.00 to $30.00 and gave the stock a “buy” rating in a research note on Wednesday. Four research analysts have rated the stock with a Buy rating, twelve have issued a Hold rating and three have issued a Sell rating to the company. According to data from MarketBeat.com, RXO has an average rating of “Hold” and a consensus target price of $23.57.

RXO Stock Performance

Shares of NYSE:RXO opened at $28.52 on Thursday. The company has a market cap of $4.70 billion, a P/E ratio of -46.76 and a beta of 2.03. The company has a debt-to-equity ratio of 0.28, a quick ratio of 1.27 and a current ratio of 1.27. RXO has a one year low of $10.43 and a one year high of $29.86. The business’s 50-day simple moving average is $25.54 and its 200 day simple moving average is $18.99.

RXO (NYSE:RXO) last released its quarterly earnings results on Thursday, May 7th. The company reported ($0.09) EPS for the quarter, hitting the consensus estimate of ($0.09). The firm had revenue of $1.43 billion for the quarter, compared to analyst estimates of $1.34 billion. RXO had a negative return on equity of 1.16% and a negative net margin of 1.83%.RXO’s revenue for the quarter was down .6% on a year-over-year basis. During the same period in the previous year, the company posted ($0.03) EPS. On average, sell-side analysts forecast that RXO will post 0.07 earnings per share for the current fiscal year.

Institutional Trading of RXO

Several institutional investors and hedge funds have recently bought and sold shares of the company. City Holding Co. increased its holdings in shares of RXO by 227.6% in the 2nd quarter. City Holding Co. now owns 1,245 shares of the company’s stock valued at $34,000 after acquiring an additional 865 shares during the last quarter. Geneos Wealth Management Inc. acquired a new position in RXO in the first quarter worth $30,000. Cassaday & Co Wealth Management LLC bought a new stake in RXO during the first quarter valued at $29,000. Flagship Harbor Advisors LLC bought a new stake in RXO during the fourth quarter valued at $25,000. Finally, Quarry LP acquired a new stake in shares of RXO during the third quarter worth $33,000. Institutional investors and hedge funds own 92.73% of the company’s stock.

Trending Headlines about RXO

Here are the key news stories impacting RXO this week:

• Positive Sentiment: Truist Financial raised its price target on RXO from $26 to $30 and reiterated a buy rating, signaling confidence in further upside from current levels. Analyst update via Benzinga
• Positive Sentiment: BMO Capital Markets initiated coverage with an outperform rating and a $35 price target, one of the more bullish calls in the latest batch. BMO Capital Markets initiation via Benzinga
• Neutral Sentiment: Goldman Sachs raised its target from $18 to $20 but kept a neutral rating, suggesting valuation may be more limited despite the higher target. Goldman Sachs update via Benzinga
• Neutral Sentiment: Citizens JMP initiated coverage with a market perform rating, indicating a more cautious stance and no strong conviction either way. Citizens JMP coverage via Zacks
• Neutral Sentiment: Susquehanna also lifted its price target to $20, but that still sits well below the current trading level, implying limited near-term upside from their perspective. Susquehanna update

About RXO

RXO Inc (NYSE: RXO) is a leading asset-light provider of digital freight brokerage and managed transportation solutions. The company leverages a proprietary technology platform to connect shippers with a network of third-party carriers, enabling optimized route planning, real-time shipment tracking, and dynamic pricing. RXO’s end-to-end service model spans full truckload, less-than-truckload (LTL), intermodal and cross-border freight movements, designed to improve efficiency and reduce transportation costs for its customers.

Operating primarily across North America, RXO serves a diverse base of shippers in industries ranging from retail and consumer goods to manufacturing and automotive.